TABLETING PROPERTIES OF THERMALLY ACTIVATED COW BONE POWDER IN HIGH DOSE FORMULATION
Journal Title: International Journal of Pharmaceutical Development & Technology - Year 2016, Vol 6, Issue 2
Abstract
ABSTRACT Activated cow bone powder was evaluated and found suitable as a diluent in the formulation of low and high dose drugs. This study was conducted in order to compare the diluent properties of dicalcium phosphate (DCP) and activated bone powder (ABP) in the formulation of high dose drugs. The mixed powders were pelletized with the specac pelletization machine, using a compaction force between 10-20 metric tonnes. A sample weight of 666 mg of the granules was used to calibrate the volumetric fill of the die using 12.5 mm punch and die set. The appropriate compression force which varied from 10-20 metric tonnes was applied to compress the granules into tablets. The formulated metronidazole tablet was evaluated for properties such as weight uniformity, thickness, crushing strength, friability, disintegration and organoplastic. Compressibility of the pellets increased with decrease in particle size fractions, and the ABP compressibility was found to be higher than that of DCP. The crushing strength of compacts formed, decreased with increase in initial particle size fraction. The disintegration times were within the acceptable time limit. The hardness of the tablets containing same formulation with ABP compared with DCP was higher in all cases. The friability values of formulations I and II of the tablets ranged between 0.4 to 0.8%, all within the value of not more than 1% standard, normally fixed by most tablet manufacturing industries. The tablet weight variations of <2% showed that the weights of the tablets were uniform. Activated cow bone powder was found to be better direct compressible diluents than the commercially available dicalcium phosphate for high dose drugs such as metronidazole. Keywords: Formulation, Metronidazole, Activated bone powder.
Authors and Affiliations
Emenike IV1* , Timothy SY2 , Okpanachi GO1 , Musa H3
Keywords
Related Articles
- EP ID EP101549
- DOI -
- Views 113
- Downloads 0
SOLID LIPID NANOPARTICLES: FOR ENHANCEMENT OF ORAL BIOAVAILABILITY
Solid lipid nanoparticles are emerging as alternative carriers to colloidal systems for controlled and targeted drug delivery. SLNs combine the advantages of different colloidal carriers, like emulsions, liposome’s...
PREDICTION OF MORTALITY IN PATIENTS WITH COMBINED CLOSED ABDOMINAL INJURIES
ABSTRACT On the basis of randomized concurrent retrospective study of treatment outcomes of 193 victims with combined closed abdominal trauma TRISS and MODS-II diagnostic scales were evaluated for prediction the...
A VALIDATED RP-HPLC DETERMINATION OF LAMIVUDINE IN VARIOUS DOSAGE FORMS AS PER ICH GUIDELINES
A simple, accurate and reproducible RP-HPLC method has been developed for the determination of Lamivudine in tablet dosage form and in liquid dosage form. Chromatography was carried out on a Thermo Hypersil ODS-C18...
DESIGN AND EVALUATION OF GELATIN MICROSPHERES CONTAINING DICLOFENAC SODIUM
Microspheres are characteristically free flowing powders consisting of proteins or synthetic polymers which arebiodegradable in nature and ideally having a particle size less than 200 μm. The present study is aimed...
RECENT TRENDS IN INSULIN DRUG DELIVERY SYSTEM
The advanced methods of insulin delivery systems would gradually progress toward physiological insulin replacement and reduce the long-term complications of diabetes mellitus. Thus, a feasible alternative route f...